Skip to main content
Log in

eNOS polymorphism associated with metabolic syndrome in children and adolescents

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

We investigated whether genetic polymorphisms in the endothelial nitric oxide (eNOS) gene (T786C in the promoter region, Glu298Asp in exon 7, and 4b/4a in intron 4) or eNOS haplotypes are associated with metabolic syndrome (MetS) in obese children and adolescents. We studied 242 subjects: 108 healthy (controls), 64 normotensive obese, and 70 obese children and adolescents with MetS. Genotypes were determined by Taqman® allele discrimination assay and real-time polymerase chain reaction (PCR), and PCR followed by fragment separation by electrophoresis. We compared the distribution of eNOS genotypes, alleles, and haplotypes in the three groups of subjects. The CC genotype for the T786C polymorphism was more common in the MetS group than in the control group (OR = 3.27; CI 1.81–9.07; P < 0.05). However, we found no significant differences in the distribution of eNOS haplotypes (P > 0.00625; P for significance after correction for multiple comparisons). Our findings suggest that while eNOS haplotypes are not relevant, the CC genotype for the T786C polymorphism is associated with MetS in obese children and adolescents. Further studies examining interactions of eNOS haplotypes with environmental factors and other genetic markers are warranted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Biro FM, Wien M (2010) Childhood obesity and adult morbidities. Am J Clin Nutr 91(5):1499S–1505S

    Article  PubMed  Google Scholar 

  2. De Ferranti SD, Osganian SK (2007) Epidemiology of paediatric metabolic syndrome and type 2 diabetes mellitus. Diab Vasc Dis Res 4(4):285–296

    Article  PubMed  Google Scholar 

  3. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S (2004) Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350(23):2362–2374

    Article  PubMed  CAS  Google Scholar 

  4. Yetik-Anacak G, Catravas JD (2006) Nitric oxide and the endothelium: history and impact on cardiovascular disease. Vasc Pharmacol 45(5):268–276

    Article  PubMed  CAS  Google Scholar 

  5. Gomes VA, Casella-Filho A, Chagas AC, Tanus-Santos JE (2008) Enhanced concentrations of relevant markers of nitric oxide formation after exercise training in patients with metabolic syndrome. Nitric Oxide 19(4):345–350

    Article  PubMed  CAS  Google Scholar 

  6. Huang PL (2009) eNOS, metabolic syndrome and cardiovascular disease. Trends Endocrinol Metab 20(6):295–302

    Article  PubMed  CAS  Google Scholar 

  7. Cooke JP, Dzau VJ (1997) Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med 48:489–509

    Article  PubMed  CAS  Google Scholar 

  8. Kojda G, Laursen JB, Ramasamy S, Kent JD, Kurz S, Burchfield J, Shesely EG, Harrison DG (1999) Protein expression, vascular reactivity and soluble guanylate cyclase activity in mice lacking the endothelial cell nitric oxide synthase: contributions of NOS isoforms to blood pressure and heart rate control. Cardiovasc Res 42(1):206–213

    Article  PubMed  CAS  Google Scholar 

  9. Cook S, Hugli O, Egli M, Vollenweider P, Burcelin R, Nicod P, Thorens B, Scherrer U (2003) Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice. Swiss Med Wkly 133(25–26):360–363

    PubMed  Google Scholar 

  10. Sandrim VC, Coelho EB, Nobre F, Arado GM, Lanchote VL, Tanus-Santos JE (2006) Susceptible and protective eNOS haplotypes in hypertensive black and white subjects. Atherosclerosis 186(2):428–432

    Article  PubMed  CAS  Google Scholar 

  11. Sandrim VC, de Syllos RW, Lisboa HR, Tres GS, Tanus-Santos JE (2006) Endothelial nitric oxide synthase haplotypes affect the susceptibility to hypertension in patients with type 2 diabetes mellitus. Atherosclerosis 189(1):241–246

    Article  PubMed  CAS  Google Scholar 

  12. Sandrim VC, Palei AC, Cavalli RC, Araujo FM, Ramos ES, Duarte G, Tanus-Santos JE (2008) eNOS haplotypes associated with gestational hypertension or preeclampsia. Pharmacogenomics 9(10):1467–1473

    Article  PubMed  CAS  Google Scholar 

  13. Souza-Costa DC, Belo VA, Silva PS, Sertorio JT, Metzger IF, Lanna CM, Machado MA, Tanus-Santos JE (2011) eNOS haplotype associated with hypertension in obese children and adolescents. Int J Obes (Lond) 35(3):387–392

    Article  CAS  Google Scholar 

  14. Monti LD, Barlassina C, Citterio L, Galluccio E, Berzuini C, Setola E, Valsecchi G, Lucotti P, Pozza G, Bernardinelli L, Casari G, Piatti P (2003) Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome. Diabetes 52(5):1270–1275

    Article  PubMed  CAS  Google Scholar 

  15. Fernandez ML, Ruiz R, Gonzalez MA, Ramirez-Lorca R, Couto C, Ramos A, Gutierrez-Tous R, Rivera JM, Ruiz A, Real LM, Grilo A (2004) Association of NOS3 gene with metabolic syndrome in hypertensive patients. Thromb Haemost 92(2):413–418

    PubMed  CAS  Google Scholar 

  16. Alkharfy KM, Al-Daghri NM, Al-Attas OS, Alokail MS, Mohammed AK, Vinodson B, Clerici M, Kazmi U, Hussain T, Draz HM (2012) Variants of endothelial nitric oxide synthase gene are associated with components of metabolic syndrome in an Arab population. Endocr J 59(3):253–263

    Article  PubMed  CAS  Google Scholar 

  17. Metzger IF, Sertorio JT, Tanus-Santos JE (2007) Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes. Free Radic Biol Med 43(6):987–992

    Article  PubMed  CAS  Google Scholar 

  18. Metzger IF, Souza-Costa DC, Marroni AS, Nagassaki S, Desta Z, Flockhart DA, Tanus-Santos JE (2005) Endothelial nitric oxide synthase gene haplotypes associated with circulating concentrations of nitric oxide products in healthy men. Pharmacogenet Genomics 15(8):565–570

    Article  PubMed  CAS  Google Scholar 

  19. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R, Mei Z, Curtin LR, Roche AF, Johnson CL (2000) CDC growth charts: United States. Adv Data 314:1–27

    PubMed  Google Scholar 

  20. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH (2003) Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988–1994. Arch Pediatr Adolesc Med 157(8):821–827

    Article  PubMed  Google Scholar 

  21. Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C (2005) Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 115(4):e500–e503

    Article  PubMed  Google Scholar 

  22. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents (1996) Update on the 1987 task force report on high blood pressure in children and adolescents: a working group report from the national high blood pressure education program. Pediatrics 98(4 Pt 1):649–658

    Google Scholar 

  23. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18(6):499–502

    PubMed  CAS  Google Scholar 

  24. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412–419

    Article  PubMed  CAS  Google Scholar 

  25. Marroni AS, Metzger IF, Souza-Costa DC, Nagassaki S, Sandrim VC, Correa RX, Rios-Santos F, Tanus-Santos JE (2005) Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphisms. Nitric Oxide 12(3):177–182

    Article  PubMed  CAS  Google Scholar 

  26. Tanus-Santos JE, Desai M, Flockhart DA (2001) Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics 11(8):719–725

    Article  PubMed  CAS  Google Scholar 

  27. Miyamoto Y, Saito Y, Nakayama M, Shimasaki Y, Yoshimura T, Yoshimura M, Harada M, Kajiyama N, Kishimoto I, Kuwahara K, Hino J, Ogawa E, Hamanaka I, Kamitani S, Takahashi N, Kawakami R, Kangawa K, Yasue H, Nakao K (2000) Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a –786T → C mutation associated with coronary spastic angina. Hum Mol Genet 9(18):2629–2637

    Article  PubMed  CAS  Google Scholar 

  28. Asif AR, Oellerich M, Armstrong VW, Hecker M, Cattaruzza M (2009) T786C polymorphism of the NOS-3 gene and the endothelial cell response to fluid shear stress-a proteome analysis. J Proteome Res 8(6):3161–3168

    Article  PubMed  CAS  Google Scholar 

  29. Ohtoshi K, Yamasaki Y, Gorogawa S, Hayaishi-Okano R, Node K, Matsuhisa M, Kajimoto Y, Hori M (2002) Association of (−)786T–C mutation of endothelial nitric oxide synthase gene with insulin resistance. Diabetologia 45(11):1594–1601

    Article  PubMed  CAS  Google Scholar 

  30. Souza-Costa DC, Belo VA, Silva PS, Metzger IF, Lanna CM, Machado MA, Tanus-Santos JE (2011) eNOS haplotype associated with hypertension in obese children and adolescents. Int J Obes 35(3):387–392

    Article  CAS  Google Scholar 

  31. Sandrim VC, Yugar-Toledo JC, Desta Z, Flockhart DA, Moreno H Jr, Tanus-Santos JE (2006) Endothelial nitric oxide synthase haplotypes are related to blood pressure elevation, but not to resistance to antihypertensive drug therapy. J Hypertens 24(12):2393–2397

    Article  PubMed  CAS  Google Scholar 

  32. Sandrim VC, de Syllos RW, Lisboa HR, Tres GS, Tanus-Santos JE (2007) Influence of eNOS haplotypes on the plasma nitric oxide products concentrations in hypertensive and type 2 diabetes mellitus patients. Nitric Oxide 16(3):348–355

    Article  PubMed  CAS  Google Scholar 

  33. González-Sánchez JL, Martínez-Larrad MT, Sáez ME, Zabena C, Martínez-Calatrava MJ, Serrano-Ríos M (2007) Endothelial nitric oxide synthase haplotypes are associated with features of metabolic syndrome. Clin Chem 53(1):91–97

    Article  PubMed  Google Scholar 

  34. Ford ES, Li C, Cook S, Choi HK (2007) Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation 115(19):2526–2532

    Article  PubMed  CAS  Google Scholar 

  35. Metzger IF, Ishizawa MH, Rios-Santos F, Carvalho WA, Tanus-Santos JE (2011) Endothelial nitric oxide synthase gene haplotypes affect nitrite levels in black subjects. Pharmacogenomics J 11(6):393–399

    Article  PubMed  CAS  Google Scholar 

  36. Lacchini R, Silva PS, Tanus-Santos JE (2010) A pharmacogenetics-based approach to reduce cardiovascular mortality with the prophylactic use of statins. Basic Clin Pharmacol Toxicol 106(5):357–361

    PubMed  CAS  Google Scholar 

  37. Nagassaki S, Sertorio JT, Metzger IF, Bem AF, Rocha JB, Tanus-Santos JE (2006) eNOS gene T786C polymorphism modulates atorvastatin-induced increase in blood nitrite. Free Radic Biol Med 41(7):1044–1049

    Article  PubMed  CAS  Google Scholar 

  38. Montenegro MF, Neto-Neves EM, Dias-Junior CA, Ceron CS, Castro MM, Gomes VA, Kanashiro A, Tanus-Santos JE (2010) Quercetin restores plasma nitrite and nitroso species levels in renovascular hypertension. Naunyn Schmiedebergs Arch Pharmacol 382(4):293–301

    Article  PubMed  CAS  Google Scholar 

  39. Montenegro MF, Pinheiro LC, Amaral JH, Marcal DM, Palei AC, Costa-Filho AJ, Tanus-Santos JE (2012) Antihypertensive and antioxidant effects of a single daily dose of sodium nitrite in a model of renovascular hypertension. Naunyn Schmiedebergs Arch Pharmacol 385(5):509–517

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by Fundaçao de Amparo a Pesquisa do Estado de Sao Paulo, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico and IMEPEN Foundation at Juiz de Fora.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jose E. Tanus-Santos.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 32 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miranda, J.A., Belo, V.A., Souza-Costa, D.C. et al. eNOS polymorphism associated with metabolic syndrome in children and adolescents. Mol Cell Biochem 372, 155–160 (2013). https://doi.org/10.1007/s11010-012-1456-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-012-1456-y

Keywords

Navigation